These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3145878)

  • 1. The effect of gonadotrophin releasing hormone analogue on height prognosis in growth hormone deficiency and normal puberty.
    Stanhope R; Brook CG
    Eur J Pediatr; 1988 Dec; 148(3):200-2. PubMed ID: 3145878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final height in sexually precocious girls after therapy with an intranasal analogue of gonadotrophin-releasing hormone (buserelin).
    Stasiowska B; Vannelli S; Benso L
    Horm Res; 1994; 42(3):81-5. PubMed ID: 7995616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to improve height prediction in short-stature pubertal adolescents by inhibiting puberty with luteinizing hormone-releasing hormone analogue.
    Lindner D; Job JC; Chaussain JL
    Eur J Pediatr; 1993 May; 152(5):393-6. PubMed ID: 8319702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of growth hormone therapy on spontaneous sexual development.
    Stanhope R; Albanese A; Hindmarsh P; Brook CG
    Horm Res; 1992; 38 Suppl 1():9-13. PubMed ID: 1295821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with a gonadotropin-releasing-hormone analog and attainment of full height potential in a male monozygotic twin with gonadotropin-releasing hormone-dependent precocious puberty.
    Ishii T; Sato S; Anzo M; Sasaki G; Hasegawa T; Tamai S; Matsuo N
    Eur J Pediatr; 1999 Nov; 158(11):933-5. PubMed ID: 10541952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of growth hormone deficiency through puberty.
    Stanhope R; Uruena M; Hindmarsh P; Leiper AD; Brook CG
    Acta Paediatr Scand Suppl; 1991; 372():47-52; discussion 53. PubMed ID: 1927519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy.
    Hopwood NJ; Hintz RL; Gertner JM; Attie KM; Johanson AJ; Baptista J; Kuntze J; Blizzard RM; Cara JF; Chernausek SD
    J Pediatr; 1993 Aug; 123(2):215-22. PubMed ID: 8345416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone.
    Cara JF; Kreiter ML; Rosenfield RL
    J Pediatr; 1992 May; 120(5):709-15. PubMed ID: 1533661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of central precocious puberty with an intranasal analogue of GnRH (Buserelin).
    Bourguignon JP; Van Vliet G; Vandeweghe M; Malvaux P; Vanderschueren-Lodeweyckx M; Craen M; Du Caju MV; Ernould C
    Eur J Pediatr; 1987 Nov; 146(6):555-60. PubMed ID: 3123239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth of short normal children in puberty treated for 3 years with growth hormone alone or in association with gonadotropin-releasing hormone agonist.
    Job JC; Toublanc JE; Landier F
    Horm Res; 1994; 41(5-6):177-84. PubMed ID: 7959618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [LH-RH agonist in subjects treated with growth hormone for somatotropin deficiency. Development of growth velocity and prediction of body height].
    Leheup B; Schaeffer L; Jeandel C; Pierson M
    Pediatrie; 1992; 47(4):291-5. PubMed ID: 1329014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined treatment with growth hormone and gonadotropin-releasing hormone analogues in children with isolated growth hormone deficiency.
    Saggese G; Cesaretti G; Andreani G; Carlotti C
    Acta Endocrinol (Copenh); 1992 Oct; 127(4):307-12. PubMed ID: 1449042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of precocious puberty using an intranasal luteinizing hormone-releasing hormone analogue: Buserelin.
    Low LC; Wang C; Cheung PT; Chan FL
    Aust Paediatr J; 1989 Oct; 25(5):274-8. PubMed ID: 2511831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of manipulation of puberty on growth.
    Lee PA
    Horm Res; 2003; 60(Suppl 1):60-7. PubMed ID: 12955020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final height after combined growth hormone and GnRH analogue treatment in adopted girls with early puberty.
    Tuvemo T; Jonsson B; Gustafsson J; Albertsson-Wikland K; Aronson AS; Häger A; Ivarson S; Kriström B; Marcus C; Nilsson KO; Westgren U; Westphal O; Aman J; Proos LA
    Acta Paediatr; 2004 Nov; 93(11):1456-62. PubMed ID: 15513572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty: influence on growth and predicted final height. The German-Dutch Precocious Puberty Study Group.
    Partsch CJ; Hümmelink R; Peter M; Sippell WG; Oostdijk W; Odink RJ; Drop SL
    Horm Res; 1993; 39(3-4):111-7. PubMed ID: 8262471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between puberty and growth at adolescence in growth-hormone-deficient males: effect of growth hormone and of associated gonadal suppression therapy.
    Tanaka T; Yoshizawa A; Tanae A; Hibi I; Shizume K
    Horm Res; 1990; 33 Suppl 4():102-5. PubMed ID: 2147164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of central precocious puberty using an intranasal LHRH analogue (buserelin).
    Stanhope R; Adams J; Brook CG
    Clin Endocrinol (Oxf); 1985 Jun; 22(6):795-806. PubMed ID: 3926352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Growth hormone treatment of children with short stature secondary to intrauterine growth retardation].
    Chaussain JL; Carel JC
    Arch Pediatr; 1998; 5 Suppl 4():345S-347S. PubMed ID: 9853081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.